DE602006005491D1 - Kerne und mikrokapseln für die parenterale verabreichung und herstellungsverfahren dafür - Google Patents

Kerne und mikrokapseln für die parenterale verabreichung und herstellungsverfahren dafür

Info

Publication number
DE602006005491D1
DE602006005491D1 DE602006005491T DE602006005491T DE602006005491D1 DE 602006005491 D1 DE602006005491 D1 DE 602006005491D1 DE 602006005491 T DE602006005491 T DE 602006005491T DE 602006005491 T DE602006005491 T DE 602006005491T DE 602006005491 D1 DE602006005491 D1 DE 602006005491D1
Authority
DE
Germany
Prior art keywords
microscopes
nucleus
manufacturing
parenteral administration
method therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006005491T
Other languages
German (de)
English (en)
Inventor
Nils Ove Gustafsson
Monica Joensson
Timo Laakso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stratosphere Pharma AB
Original Assignee
Stratosphere Pharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stratosphere Pharma AB filed Critical Stratosphere Pharma AB
Publication of DE602006005491D1 publication Critical patent/DE602006005491D1/de
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602006005491T 2005-05-27 2006-05-24 Kerne und mikrokapseln für die parenterale verabreichung und herstellungsverfahren dafür Active DE602006005491D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05011516 2005-05-27
EP05028165A EP1726299A3 (en) 2005-05-27 2005-12-22 Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
PCT/EP2006/004940 WO2006125620A2 (en) 2005-05-27 2006-05-24 Cores and microcapsules suitable for parenteral administration as well as process for their manufacture

Publications (1)

Publication Number Publication Date
DE602006005491D1 true DE602006005491D1 (de) 2009-04-16

Family

ID=36935013

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006005491T Active DE602006005491D1 (de) 2005-05-27 2006-05-24 Kerne und mikrokapseln für die parenterale verabreichung und herstellungsverfahren dafür

Country Status (7)

Country Link
EP (2) EP1726299A3 (https=)
JP (1) JP5080453B2 (https=)
AT (1) ATE424190T1 (https=)
CA (1) CA2609891A1 (https=)
DE (1) DE602006005491D1 (https=)
DK (1) DK1906928T3 (https=)
WO (1) WO2006125620A2 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
GB0707612D0 (en) 2007-04-19 2007-05-30 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
CA2687983A1 (en) 2007-05-23 2008-12-04 Allergan, Inc. Coated hyaluronic acid particles
WO2008147867A2 (en) 2007-05-23 2008-12-04 Allergan, Inc. Cross-linked collagen and uses thereof
US8318695B2 (en) 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
US8114898B2 (en) 2007-11-16 2012-02-14 Allergan, Inc. Compositions and methods for treating purpura
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
CN102905677A (zh) 2010-03-12 2013-01-30 阿勒根工业有限公司 用于改善皮肤状况的包含透明质烷聚合物和甘露糖醇的流体组合物
ES2585388T5 (es) 2010-03-22 2019-08-08 Allergan Inc Hidrogeles reticulados de polisacárido y proteína-polisacárido para aumento de tejido blando
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
KR102312056B1 (ko) 2011-06-03 2021-10-12 알러간 인더스트리 에스에이에스 항산화제를 포함하는 피부 충전제 조성물
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
PL3256179T3 (pl) 2015-02-13 2020-05-18 Allergan Industrie, Sas Implanty do kształtowania, uwydatniania lub korygowania cech twarzy takich jak broda
WO2025137151A2 (en) 2023-12-18 2025-06-26 The Johns Hopkins University Dendrimer compositions for the treatment of atherosclerosis, obesity, and metabolic syndromes
CN118146569B (zh) * 2024-01-24 2024-11-22 中国海洋大学 透明质酸-青蒿琥酯-聚精氨酸纳米粒、制备方法及应用
WO2025265116A1 (en) 2024-06-21 2025-12-26 Georgia State University Research Foundation, Inc. Nanobodies to henipavirus and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
EP0576675A4 (en) * 1991-03-25 1994-06-01 Fujisawa Pharmaceutical Co Long-acting pharmaceutical preparation
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
KR100201352B1 (ko) * 1995-03-16 1999-06-15 성재갑 단일주사 백신 제형
SE505146C2 (sv) 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning
CA2296620A1 (en) * 1997-07-18 1999-01-28 Kris P. Antonsen Methods of removing residual solvent from nasal drug delivery compositions
SE9903236D0 (sv) 1999-09-10 1999-09-10 Astra Ab Method to obtain microparticles
RU2002112751A (ru) * 1999-11-12 2004-02-27 Файброджен, Инк. (Us) Рекомбинантные желатины
AU9445801A (en) 2000-10-06 2002-04-15 Bioglan Ab Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight
CA2424888A1 (en) 2000-10-06 2002-04-11 Jagotec Ag Pharmaceutically acceptable starch
CA2424896A1 (en) * 2000-10-06 2002-04-11 Jagotec Ag A controlled-release, parenterally administrable microparticle preparation

Also Published As

Publication number Publication date
DK1906928T3 (da) 2009-04-20
EP1906928A2 (en) 2008-04-09
EP1906928B1 (en) 2009-03-04
EP1726299A3 (en) 2007-04-18
WO2006125620A2 (en) 2006-11-30
JP5080453B2 (ja) 2012-11-21
EP1726299A2 (en) 2006-11-29
CA2609891A1 (en) 2006-11-30
ATE424190T1 (de) 2009-03-15
WO2006125620A3 (en) 2007-08-02
JP2008542220A (ja) 2008-11-27

Similar Documents

Publication Publication Date Title
DE602006005491D1 (de) Kerne und mikrokapseln für die parenterale verabreichung und herstellungsverfahren dafür
ATE551046T1 (de) Polymere duftkapseln und ihre herstellung
ATE447564T1 (de) Zwischenprodukte für die herstellung von trans-5- chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenzä , 3:6,7üoxepinoä4,5-cüpyrrol
BRPI0611350B8 (pt) formulação, seus usos e seu processo de fabricação,e artigo de fabricação
ATE547171T1 (de) Brennstoffkassetten für brennstoffzellen und herstellungsverfahren dafür
ECSP11011079A (es) Nuevos compuestos de hidroxiareno.
MA29870B1 (fr) Nouveaux dérivés de 1-azabicycloalkyles dans le traitement de troubles psychotiques et neurodégénératifs
EA200600320A1 (ru) γ-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ
EA200600321A1 (ru) βd-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ
EP2163619A4 (en) ROSE WITH FLAVON AND MALVIDINE AND METHOD OF MANUFACTURE THEREOF
EP2159282A4 (en) ROSE-FLAVON AND DELPHINIDINE AND METHOD OF PREPARING THEREOF
GT200200280A (es) Lactamas como antagonistas de taquiquininas
GT200500394A (es) 18-metil-19-nor-17-oregn-4-en-21, 17-carbolactonas, asi como preparaciones farmaceuticas que las contienen
NI200700139A (es) Formulaciones de benzoxazoles sustituidos
ATE536864T1 (de) Metoprololsuccinat tabletten mit verlängerter freisetzung und verfahren für deren herstellung
EP1955766A4 (en) CATALYST FOR ETHYLENE OXIDE GENERATION, PRODUCTION METHOD AND METHOD FOR PRODUCING ETHYLENE OXIDE
DE602006019732D1 (de) Indolylmaleimidderivate
EP1953808A4 (en) METHOD FOR PRODUCING AN EPITAXIAL WAFERS AND EPITAXIAL WAFER
ATE517900T1 (de) Heptarylen-und octarylentetracarbonsäurediimide und deren herstellung
FR2895406B1 (fr) Procede pour la fabrication de 2,3-dimethylbut-1-ene
EP1808243A4 (en) METHOD FOR THE PRODUCTION OF A POROUS SINTER BODY, POROUS SINTERING MATERIAL AND POROUS SINTER BODY
EP1614671A4 (en) PROCESS FOR THE PREPARATION OF ISOPRENE
EP2241571A4 (en) STABLE 6-METHOXY-2 ', 3'-DIDEOXYGUANOSINE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THEREWITH
EP1845084A4 (en) PROCESS FOR PREPARING (Z) -1-PHENYL-1- (N, N-DIETHYLAMINOCARBONYL) IDOMETHYLCYCLOPROPANE
UY29821A1 (es) Derivados de 5,6-dihidropirazolo(3,4)(1,4)diazepin-4(1h)-ona, procesos de preparación de dichos derivados, composiciones farmacéuticas conteniéndolos y aplicaciones.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition